The Biochemistry Behind the Potential Cardiovascular Protection by Dietary Flavonoids

Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology

Volumn , Issue , 2009, Pages 137-158

  Loke, Wai Mun ^a,b   Hodgson, Jonathan M ^a   Croft, Kevin D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Biochemistry behind potential cardiovascular protection by dietary flavonoids; Dietary flavonoids and platelet reactivity; Potential cardiovascular protection

Indexed keywords

EID: 84889627806     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470531792.ch5     Document Type: Chapter

References (126)

1. Awtry EH, Loscalzo J. 2000. Aspirin. Circulation 101:1206-1218.
2. Badia E, Sacanella E, Fernandez-Sola J, Nicolas JM, Antunez E, Rotilio D, de Gaetano G, Urbano-Marquez A, Estruch R. 2004. Decreased tumor necrosis factor-induced adhesion of human monocytes to endothelial cells after moderate alcohol consumption. Am J Clin Nutr 80:225-230.
3. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW. 2003. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440-1445.
4. Benito S, Lopez D, Saiz MP, Buxaderas S, Sanchez J, Puig-Parellada P, Mitjavila MT. 2002. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br J Pharmacol 135:910-916.
5. Blache D, Durand P, Prost M, Loreau N. 2002. (+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo. Free Radic Biol Med 33:1670-1680.
6. Bodin S, Tronchere H, Payrastre B. 2003. Lipid rafts are critical membrane domains in blood platelet activation processes. Biochim Biophys Acta 1610:247-257.
7. Borradaile NM, de Dreu LE, Huff MW. 2003. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 52:2554-2561.
8. Boyle S, Dobson V, Duthie S, Hinselwood D, Kyle JA, Collins AR. 2000. Bioavailability and efficiency of rutin as an antioxidant: A human supplementation study. Eur J Clin Nutr 54:774-782.
9. Brennan M-L, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. 2003. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595-1604.
10. Caccetta RA, Burke V, Mori TA, Beilin LJ, Puddey IB, Croft KD. 2001. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. Free Radic Biol Med 30:636-642.
11. Cartron E, Fouret G, Carbonneau M-A, Lauret Cel, Michel Fco, Monnier L, Descomps B, Léger CL. 2003. Red-wine beneficial long-term effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine-description of two O-methylated derivatives of gallic acid in humans. Free Radic Res 37:1021-1035.
12. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. 1994. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 14:753-759.
13. Celermajer DS. 1997. Endothelial dysfunction: Does it matter? Is it reversible? J Am Coll Cardiol 30:325-333.
14. Choi JS, Chung HY, Kang SS, Jung MJ, Kim JW, No JK, Jung HA. 2002. The structure-activity relationship of flavonoids as scavengers of peroxynitrite. Phytother Res 16:232-235.
15. Comalada M, Ballester I, Bailon E, Sierra S, Xaus J, Galvez J, Medina FSD, Zarzuelo A. 2006. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structureactivity relationship. Biochem Pharmacol 72:1010-1021.
16. Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, Wiseman SA, Muesing RA, Chen SC. 2003. Black tea consumption reduces total and ldl cholesterol in mildly hypercholesterolemic adults. J Nutr 133:3298S-3302.
17. Day AJ, Bao Y, Morgan MRA, Williamson G. 2000. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29:1234-1243.
18. Debry P, Nash EA, Neklason DW, Metherall JE. 1997. Role of multidrug resistance p-glycoproteins in cholesterol esterification. J Biol Chem 272:1026-1031.
19. Demeule M, Michaud-Levesque J, Annabi B, Gingras D, Boivin D, Jodoin J, Lamy S, Bertrand Y, Beliveau R. 2002. Green tea catechins as novel antitumor and antiangiogenic compounds. Curr Med Chem 2:441-463.
20. Demrow HS, Slane PR, Folts JD. 1995. Administration of wine and grape juice inhibits in-vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 91:1182-1188.
21. Duffy SJ, Vita JA, Holbrook M, Swerdloff PL, Keaney JFJr. 2001. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21:1084-1089.
22. Duthie G, Crozier A. 2000. Plant-derived phenolic antioxidants. Curr Opin Lipidol 11:43-47.
23. Estruch R, Sacanella E, Badia E, Antunez E, Nicolas JM, Fernandez-Sola J, Rotilio D, de Gaetano G, Rubin E, Urbano-Marquez A. 2004. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: A prospective randomized crossover trial: Effects of wine on inflammatory markers. Atherosclerosis 175:117-123.
24. Fisher NDL, Hughes M, Gerhard-Herman M, Hollenberg NK. 2003. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21:2281-2286.
25. Ford-Hutchinson AW. 1991. FLAP: A novel drug target for inhibiting the synthesis of leukotrienes. Trends Pharmacol Sci 12:68-70.
26. Freedman JE, Parker CIII, Li L, Perlman JA, Frei B, Ivanov V, Deak LRBS, Iafrati MD, Folts JD. 2001. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103:2792-2798.
27. Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H, Mutanen M. 1999. Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Eur J Nutr 38:149-157.
28. Fujimura Y, Tachibana H, Yamada K. 2004. Lipid raft-associated catechin suppresses the FceRI expression by inhibiting phosphorylation of the extracellular signalregulated kinase1/2. FEBS Lett 556:204-210.
29. Gago B, Lundberg JO, Barbosa RM, Laranjinha J. 2007. Red wine-dependent reduction of nitrite to nitric oxide in the stomach. Free Radic Biol Med 43:1233-1242.
30. Ganz P, Vita JA. 2003. Testing endothelial vasomotor function: Nitric oxide, a multipotent molecule. Circulation 108:2049-2053.
31. Geleijnse JM, Launer LJ, van der Kuip DA, Hofman A, Witteman JC. 2002. Inverse association of tea and flavonoid intakes with incident myocardial infarction: The Rotterdam Study. Am J Clin Nutr 75:880-886.
32. Gousset K, Wolkers WF, Tsvetkova NM, Oliver AE, Field CL, Walker NJ, Crowe JH, Tablin F. 2002. Evidence for a physiological role for membrane rafts in human platelets. J Cell Physiol 190:117-128.
33. Hakim IA, Harris RB, Brown S, Chow H-HS, Wiseman S, Agarwal S, Talbot W. 2003. Effect of increased tea consumption on oxidative DNA damage among smokers: A randomized controlled study. J Nutr 33:3303S-3309.
34. Halliwell B, Long L, Lee T, Lim S, Kelly R. 2004. Establishing biomarkers of oxidative stress: The measurement of hydrogen peroxide in human urine. Curr Med Chem 11:1085-10392.
35. Hanasaki Y, Ogawa S, Fukui S. 1994. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16:845-850.
36. Hazen SL, Zhang R, Shen Z, Wu W, Podrez EA, MacPherson JC, Schmitt D, Mitra SN, Mukhopadhyay C, Chen Y, Cohen PA, Hoff HF, Abu-Soud HM. 1999. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: Pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 85:950-958.
37. Heijnen CGM, Haenen GRMM, Vekemans JAJM, Bast A. 2001. Peroxynitrite scavenging of flavonoids: Structure activity relationship. Environ Toxicol Pharmacol 10:199-206.
38. Heiss C, Schroeter H, Balzer J, Kleinbongard P, Matern S, Sies H, Kelm M. 2006. Endothelial function, nitric oxide, and cocoa flavanols. J Cardiovasc Pharmacol 47:S128-S135.
39. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S. 1995. Flavonoids intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155:381-386.
40. Hirata K, Shimada K, Watanabe H, Otsuka R, Tokai K, Yoshiyama M, Homma S, Yoshikawa J. 2004. Black tea increases coronary flow velocity reserve in healthy male subjects. Am J Cardiol 93:1384-1388.
41. Hirvonen T, Pietinen P, Virtanen M, Ovaskainen M-L, Hakkinen S, Albanes D, Virtamo J. 2001. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 12:62-67.
42. Hodgson JM, Croft KD. 2006. Dietary flavonoids: Effects on endothelial function and blood pressure. J Sci Food Agric 86:2492-2498.
43. Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, Puddey IB. 2002a. Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. J Nutr 132:55-58.
44. Hodgson JM, Puddey IB, Burke V, Beilin LJ, Mori TA, Chan SY. 2002b. Acute effects of ingestion of black tea on postprandial platelet aggregation in humans. Br J Nutr 87:141-145.
45. Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ. 2001. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr 55:881-886.
46. Hou L, Zhou B, Yang L, Liu Z-L. 2004. Inhibition of human low density lipoprotein oxidation by flavonols and their glycosides. Chem Phys Lipids 129:209-219.
47. Huxley RR, Neil HAW. 2003. The relation between dietary flavonol intake and coronary heart disease mortality: A meta-analysis of prospective cohort studies. Eur J Clin Nutr 57:904-908.
48. Ishige K, Schubert D, Sagara Y. 2001. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30:433-446.
49. Jala VR, Haribabu B. 2004. Leukotrienes and atherosclerosis: New roles for old mediators. Trends Immunol 25:315-322.
50. Jimenez R, Lopez-Sepulveda R, Kadmiri M, Romero M, Vera R, Sanchez M, Vargas F, O'Valle F, Zarzuelo A, Duenas M, Santos-Buelga C, Duarte J. 2007. Polyphenols restore endothelial function in DOCA-salt hypertension: Role of endothelin-1 and NADPH oxidase. Free Radic Biol Med 43:462-473.
51. Justino GC, Santos MR, Canario S, Borges C, Florencio MH, Mira L. 2004. Plasma quercetin metabolites: Structure-antioxidant activity relationships. Arch Biochem Biophys 432:109-121.
52. Kawai Y, Nishikawa T, Shiba Y, Saito S, Murota K, Shibata N, Kobayashi M, Kanayama M, Uchida K, Terao J. 2008. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: Implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283:9424-9434.
53. Keli SO, Hertog MG, Feskens EJ, Kromhout D. 1996. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 156:637-642.
54. Kim JA, Formoso G, Li Y, Potenza MA, Marasciulo FL, Montagnani M, Quon MJ. 2007. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282:13736-13745.
55. Klaunig JE, Xu Y, Han C, Kamendulis LM, Chen J, Heiser C, Gordon MS, Mohler III ER. 1999. The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med 220:249-254.
56. Knekt P, Jarvinen R, Reunanen A, Maatela J. 1996. Flavonoids intake and coronary mortality in Finland: A cohort study. Br Med J 312:478-481.
57. Koga T, Meydani M. 2001. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 73:941-948.
58. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. 2002. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106:1614-1617.
59. Libby P. 2002. Inflammation in atherosclerosis. Nature 420:868-874.
60. Loest HB, Noh SK, Koo SI. 2002. Green tea extract inhibits the lymphatic absorption of cholesterol and-tocopherol in ovariectomized rats. J Nutr 132:1282-1288.
61. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD. 2008a. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88:1018-1025.
62. Loke WM, Proudfoot JM, McKinley AJ, Needs PW, Kroon PA, Hodgson JM, Croft KD. 2008b. Quercetin and its in vivo metabolites inhibit neutrophil-mediated LDL oxidation. J Agric Food Chem 56:3609-3615.
63. Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, Kroon PA, Hodgson JM, Croft KD. 2008c. Metabolic transformation has a profound effect on antiinflammatory activity of flavonoids such as quercetin: Lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol 75:1045-1053.
64. Loomis ED, Sullivan JC, Osmond DA, Pollock DM, Pollock JS. 2005. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta. J Pharmacol Exp Ther 315:1058-1064.
65. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G, Stangl K, Stangl V. 2004. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMPdependent protein kinase-, and Akt-dependent pathway and leads to endothelialdependent vasorelaxation. J Biol Chem 279:6190-6195.
66. Lotito SB, Frei B. 2006. Dietary flavonoids attenuate tumor necrosis factor-induced adhesion molecule expression in human aortic endothelial cells: Structure-function relationships and activity after first pass metabolism. J Biol Chem 281:37102-37110.
67. Machha A, Achike FI, Mustafa AM, Mustafa MR. 2007. Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 16:442-447.
68. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S-242S.
69. Mano T, Masuyama T, Yamamoto K, Naito J, Kondo H, Nagano R, Tanouchi J, Hori M, Inoue M, Kamada T. 1996. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J 131:231-238.
70. Mathur S, Devaraj S, Grundy SM, Jialal I. 2002. Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr 132:3663-3667.
71. Matsuda T, Ferreri K, Todorov I, Kuroda Y, Smith CV, Kandeel F, Mullen Y. 2005. Silymarin protects pancreatic-cells against cytokine-mediated toxicity: Implication of c-Jun NH2-terminal kinase and Janus kinase/signal transducer and activator of transcription pathways. Endocrinology 146: 175-185.
72. Meotti FC, Senthilmohan R, Harwood DT, Missau FC, Pizzolatti MG, Kettle AJ. 2008. Myricitrin as a substrate and inhibitor of myeloperoxidase: Implications for the pharmacological effects of flavonoids. Free Radic Biol Med 44:109-120.
73. Mira L, Tereza Fernandez M, Santos M, Rocha R, Helena Florencio M, Jennings KR. 2002. Interactions of flavonoids with iron and copper ions: A mechanism for their antioxidant activity. Free Radic Res 36:1199-1208.
74. Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC. 2007. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49:1993-2000.
75. Moller P, Vogel U, Pedersen A, Dragsted LO, Sandstrom B, Loft S. 2003. No effect of 600 grams fruit and vegetables per day on oxidative DNA damage and repair in healthy nonsmokers. Cancer Epidemiol Biomarkers Prev 12:1016-1022.
76. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. 2002. Tea consumption and mortality after acute myocardial infarction. Circulation 105:2476-2481.
77. Murase T, Kume N, Hase T, Shibuya Y, Nishizawa Y, Tokimitsu I, Kita T. 1999. Gallates inhibit cytokine-induced nuclear translocation of NF-kB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler Thromb Vasc Biol 19:1412-1420.
78. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM. 2001. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425.
79. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Matsumura Y. 2002. Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin Sci 103:68S-71S.
80. Oteiza PI, Erlejman AG, Verstraeten SV, Keen CL, Fraga CG. 2005. Flavonoidmembrane interactions: A protective role of flavonoids at the membrane surface? Clin Dev Immunol 12:19-25.
81. Pignatelli P, Pulcinelli FM, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F. 2000. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 72:1150-1155.
82. Pincemail J, Deby C, Thirion A, de Bruyn-Dister M, Goutier R. 1988. Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds. Cell Mol Life Sci 44:450-453.
83. Podrez EA, Abu-Soud HM, Hazen SL. 2000. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28:1717-1725.
84. Ramzy D, Rao V, Tumiati LC, Xu N, Sheshgiri R, Miriuka S. 2006. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 114:I319-I326.
85. Rassaf T, Preik M, Kleinbongard P, Lauer T, HeiX C, Strauer BE, Feelisch M, Kelm M. 2002. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 109:1241-1248.
86. Rein D, Paglieroni TG, Wun T, Pearson DA, Schmitz HH, Gosselin R, Keen CL. 2000. Cocoa inhibits platelet activation and function. Am J Clin Nutr 72:30-35.
87. Sadeghipour M, Terreux R, Phipps J. 2005. Flavonoids and tyrosine nitration: Structure-activity relationship correlation with enthalpy of formation. Toxicol in Vitro 19:155-165.
88. Sanbongi C, Suzuki N, Sakane T. 1997. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in-vitro. Cell Immunol 177:129-136.
89. Sanchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, Perez-Vizcaino F, Duarte J. 2006. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 24:75-84.
90. Santos MR, Mira L. 2004. Protection by flavonoids against the peroxynitrite-mediated oxidation of dihydrorhodamine. Free Radic Res 38:1011-1018.
91. Scalbert A, Williamson G. 2000. Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S-2085S.
92. Schewe T, Kuhn H, Sies H. 2002. Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase. J Nutr 132:1825-1829.
93. Schramm DD, Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, Lazarus SA, Schmitz HH, German JB, Keen CL. 2001. Chocolate procyanidins decrease the leukotrieneprostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 73:36-40.
94. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. 2006. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103:1024-1029.
95. Selloum L, Reichl S, Muller M, Sebihi L, Arnhold J. 2001. Effects of flavonols on the generation of superoxide anion radicals by xanthine oxidase and stimulated neutrophils. Arch Biochem Biophys 395:49-56.
96. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. 1999. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 149:162-167.
97. Sies H, Schewe T, Heiss C, Kelm M. 2005. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 81:304S-312S.
98. Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387:569-572.
99. Steffen Y, Jung T, Klotz L-O, Schewe T, Grune T, Sies H. 2007. Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: Protection by (-)-epicatechin. Free Radic Biol Med 42:955-970.
100. Steffen Y, Schewe T, Sies H. 2005. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun 331:1277-1283.
101. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD. 1999. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050-1055.
102. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. 2003. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78:123-130.
103. Stocker R, Keaney JFJr. 2004. Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381-1478.
104. Strachan FE, Newby DE, Sciberras DG, McCrea JB, Goldberg MR, Webb DJ. 2002. Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography. Br J Clin Pharmacol 54:386-394.
105. Takano-Ishikawa Y, Goto M, Yamaki K. 2006. Structure-activity relations of inhibitory effects of various flavonoids on lipopolysaccharide-induced prostaglandin E2 production in rat peritoneal macrophages: Comparison between subclasses of flavonoids. Phytomedicine 13:310-317.
106. Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ. 2003. Isoflavones reduce arterial stiffness: A placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 23:1066-1071.
107. Thompson HJ, Heimendinger J, Haegele A, Sedlacek SM, Gillette C, O'Neill C, Wolfe P, Conry C. 1999. Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. Carcinogenesis 20:2261-2266.
108. Tordera M, Ferrandiz ML, Alcaraz MJ. 1994. Influence of anti-inflammatory flavonoids on degradation and arachidonic acid release in rat neutrophils. Z Naturforsch [C] 49:235-240.
109. van den Berg R, van Vliet T, Broekmans W, Cnubben N, Vaes W, Roza L, Haenen G, Bast A, van den Berg H. 2001. A vegetable/fruit concentrate with high antioxidant capacity has no effect on biomarkers of antioxidant status in male smokers. J Nutr 131:1714-1722.
110. Vaya J, Mahmood S, Goldblum A, Aviram M, Volkova N, Shaalan A, Musa R, Tamir S. 2003. Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy. Phytochemistry 62:89-99.
111. Verstraeten SV, Keen CL, Schmitz HH, Fraga CG, Oteiza PI. 2003. Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic Biol Med 34:84-92.
112. Vieira O, Escargueil-Blanc I, Meilhac O, Basile JP, Laranjinha J, Alemeida L, Salvayre R, Negre-Salvayre A. 1998. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidised LD L. Br J Pharmacol 123: 565-573.
113. Vila L. 2004. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: Role in atherosclerosis. Med Res Rev 24:399-424.
114. Vogel RA. 1997. Coronary risk factors, endothelial function, and atherosclerosis: A review. Clin Cardiol 20:426-432.
115. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Forstermann U. 2002. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652-1658.
116. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, Kris-Etherton PM. 2001. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 74:596-602.
117. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL. 2007. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13:1176-1184.
118. Widlansky ME, Duffy SJ, Hamburg NM, Gokce N, Warden BA, Wiseman S, Keaney J, John F, Frei B, Vita JA. 2005. Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic Biol Med 38:499-506.
119. Williams RJ, Spencer JPE, Rice-Evans C. 2004. Flavonoids: Antioxidants or signalling molecules? Free Radic Biol Med 36:838-849.
120. Yochum L, Kushi LH, Meyer K, Folsom AR. 1999. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149:943-949.
121. Young J, Dragsted L, Daneshvar B, Lauridsen S, Hansen M, Sandstrom B. 2000. The effect of grape-skin extract on oxidative status. Br J Nutr 84:505-13.
122. Zern TL, Wood RJ, Greene C, West KL, Liu Y, Aggarwal D, Shachter NS, Fernandez ML. 2005. Grape polyphenols exert a cardioprotective effect in pre-and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 135:1911-1917.
123. Zern TL, West KL, Fernandez ML. 2003. Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr 133:2268-2272.
124. Zhang R, Brennan M-L, Shen Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL. 2002a Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277:46116-46122.
125. Zhang R, Shen Z, Nauseef WM, Hazen SL. 2002b Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: Systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma. Blood 99:1802-810.
126. Zhao X, Gu Z, Attele AS, Yuan C-S. 1999. Effects of quercetin on the release of endothelin, prostacyclin and tissue plasminogen activator from human endothelial cells in culture. J Ethnopharmacol 67:279-285.